XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023   232,453,190      
Beginning balance at Dec. 31, 2023 $ 166,816 $ 23 $ 1,012,773 $ (846,204) $ 224
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under employee stock purchase plan (in shares)   253,312      
Issuance of common stock under employee stock purchase plan 1,038   1,038    
Issuance of common stock upon exercise of options (in shares)   701,578      
Issuance of common stock upon exercise of options 2,183   2,183    
Issuance of common stock upon vesting of restricted stock units (in shares)   551,664      
Stock-based compensation 7,616   7,616    
Unrealized losses on available-for-sale securities (244)       (244)
Net loss (26,518)     (26,518)  
Ending balance (in shares) at Mar. 31, 2024   233,959,744      
Ending balance at Mar. 31, 2024 150,891 $ 23 1,023,610 (872,722) (20)
Beginning balance (in shares) at Dec. 31, 2024   238,015,825      
Beginning balance at Dec. 31, 2024 173,289 $ 24 1,058,548 (885,340) 57
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under employee stock purchase plan (in shares)   222,734      
Issuance of common stock under employee stock purchase plan $ 1,015   1,015    
Issuance of common stock upon exercise of options (in shares) 390,000 389,963      
Issuance of common stock upon exercise of options $ 467   467    
Issuance of common stock upon vesting of restricted stock units (in shares)   572,734      
Stock-based compensation 12,088   12,088    
Unrealized losses on available-for-sale securities (39)       (39)
Net loss (41,144)     (41,144)  
Ending balance (in shares) at Mar. 31, 2025   239,201,256      
Ending balance at Mar. 31, 2025 $ 145,676 $ 24 $ 1,072,118 $ (926,484) $ 18